advisorsecurities master

MRKMerck & Co., Inc.

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key
18747
Ticker
MRK
Type
CSCommon Stock
Exchange
New York Stock Exchange(XNYS)
Venue group
NYSE
Operating MIC
XNYS
Market
stocks
Locale
us
Currency
USD
Listed
1949-04-20
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
MRK

Detail

Enriched 2026-08-14 20:47

Market cap
$327,936,454,122.96
Shares outstanding (class)
2,469,824,415
Shares outstanding (weighted)
2,467,171,638
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
75,000
Location
RAHWAY, NJ
Description

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data